Eli Lilly Weight Loss Medication

Weight Loss, Food and Drug Administration

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now.

ABC News · 4d

Compound versions of some weight loss drugs to be restricted

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for weight loss, as is permissible by the FDA.

AOL · 2d

FBI issues safety warning about counterfeit versions of weight loss drug semaglutide

The FBI is warning the public about counterfeit compounded weight loss drugs on the market that claim to contain semaglutide, the active ingredient in Ozempic and Wegovy, two prescription medications used for weight loss.

The New York Times · 11d

Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible.

ABC News on MSN · 2d

FBI warns about counterfeit weight loss drugs

The FBI is warning about counterfeit weight loss drugs being sold that claim to have semaglutide, the key ingredient in Ozempic and Wegovy.

6don MSN

Eli Lilly plans launch of weight-loss drug in emerging markets by 2026, CFO says

(Reuters) -Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug, Mounjaro, in countries like China, India, ...

4don MSN

Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

11don MSN

Wegovy price cut: Novo Nordisk cuts the price of the weight-loss drug for the uninsured

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

STAT5d

Eli Lilly’s Dave Ricks takes home $114 million as obesity drugs fuel company’s fortunes

Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.

The Associated Press on MSN10d

Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of ...

Devdiscourse6d

Eli Lilly Expands Horizons: Launching Weight-Loss Drug in Emerging Markets

Eli Lilly is set to launch its popular weight-loss drug in emerging markets, including India, Brazil, and Mexico, by mid-2025 ...

ABC News5d

Weight-loss drugs

Experts say the growing use of weight loss drugs may be helping to reverse obesity trends. ABC News medical contributor Dr. John Brownstein breaks down the latest study. Eli Lilly says new ...

6don MSN

Is Eli Lilly Stock a Buy?

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

6don MSN

Eli Lilly plans to launch weight-loss drug in emerging markets this year

Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results